"10.1371_journal.pone.0027338","plos one","2011-11-15T00:00:00Z","Mattias Rantalainen; Blanca M Herrera; George Nicholson; Rory Bowden; Quin F Wills; Josine L Min; Matt J Neville; Amy Barrett; Maxine Allen; Nigel W Rayner; Jan Fleckner; Mark I McCarthy; Krina T Zondervan; Fredrik Karpe; Chris C Holmes; Cecilia M Lindgren","Department of Statistics, University of Oxford, Oxford, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Headington, Oxford, United Kingdom; Novo Nordisk A/S, Måløv, Denmark; NIHR Oxford Biomedical Research Centre, ORH Trust, Churchill Hospital, Oxford, United Kingdom; MRC Mammalian Genetics Unit, MRC Harwell, Harwell, Oxford, United Kingdom","Conceived and designed the experiments: CML CCH KTZ FK MIM GN MA JF. Performed the experiments: BMH RB MJN AB NWR JLM. Analyzed the data: MR GN QFW. Wrote the paper: MR BMH CML.","Co-author and MolPAGE consortium partner Jan Fleckner is affiliated with Novo Nordisk A/S, Måløv, Denmark. MolPAGE consortium partner John Anson is affiliated with Oxford Gene Technology, Oxford, UK. MolPAGE consortium partner Mats Inganäs is affiliated with Gyros AB, Uppsala, Sweden. Dr. Inganäs is also a minor shareholder of Gyros AB and inventor and co-inventor on several patents and patent applications. A list of patents and patent applications are available on request. MolPAGE consortium partner Hanno Langen is affiliated with Hoffmann-La Roche, Roche Center for Medical Genomics, Basel, Switzerland. MolPAGE consortium partner Kurt Berlin was formerly affiliated with Epigenomics AG, Berlin, Germany. MolPAGE consortium partner Thomas Bergman was formerly affiliated with Affibody AB, Stockholm, Sweden. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","11","Mattias Rantalainen","MR",16,TRUE,8,6,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
